Neuroanatomical correlates of early cognitive change in Parkinson’s disease
Objective: To identify the neuroanatomical basis of early cognitive change in Parkinson’s disease (PD). Background: 50% of PD patients develop dementia within 10 years of…Parkinson Disease Clinical Subtypes Predict Dementia and Mortality Risk
Objective: To identify PD clinical subtypes based on patterns of motor, cognitive, and psychiatric symptoms; to assess the clinical utility of each subtype in predicting…Neuropsychological changes over the first 6 years of Parkinson’s disease in the ICICLE-PD cohort
Objective: To determine the longitudinal differences in cognitive tests in participants with Parkinson’s disease (PD), and the neuropsychological tests most sensitive to change over and…Dynamic functional connectivity signature of cognitive decline in Parkinson’s disease
Objective: Aim of the present study was to characterize the dynamic changes of functional connectivity associated with Parkinson’s disease (PD) cognitive decline using dynamic functional…Predictors of Retention for Carbidopa/Levodopa Intestinal Gel in Parkinson Disease
Objective: To identify predictors of discontinuation of levodopa/carbidopa intestinal gel therapy. Background: Although levodopa/carbidopa intestinal gel (LCIG) is an established treatment for Parkinson's disease complicated…Using Brain Atrophy and Visual Dysfunction to Predict Dementia in Parkinson’s Disease
Objective: To identify areas of regional volume loss in structural brain images relating to poorer visual function and risk of dementia in Parkinson’s Disease (PD).…Neural correlates of compensatory process and impaired working memory in Parkinson’s disease during disease progression
Objective: We aimed to elucidate neural responses associated with working memory (WM) tasks in Parkinson's disease (PD) patients during disease progression. Background: PD patients often…Identification of protein biomarker/s in CSF of Parkinson’s disease (PD) with cognitive impairment
Objective: i. To identify CSF protein biomarker/s in Parkinson's disease (PD) with cognitive impairment using LC-MS/MS proteomics. ii. To estimate the level of known AD…Visual dysfunction and retinal thinning predict dementia risk in Parkinson’s disease
Objective: We assessed the role of visual measures and retinal volume (in dopaminergic layers: ganglion cell layer (GCL) and inner plexiform layer (IPL)) to predict…Neuroimaging in Parkinson’s disease dementia: Connecting the dots
Objective: To identify the neural substrates of Parkinson’s disease dementia (PDD) and Parkinson’s disease with Mild Cognitive Impairment (PD-MCI) using a network mapping approach. Background:…
- « Previous Page
- 1
- …
- 20
- 21
- 22
- 23
- 24
- …
- 39
- Next Page »